[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy]

Nihon Rinsho. 2005 Nov:63 Suppl 11:569-72.

[Article in Japanese]

Authors

Takuto Hikichi¹, Atsushi Irisawa, Chikako Abe, Katsutoshi Obara, Yukio Sato

Affiliation

¹ Department of Internal Medicine II, Fukushima Medical University School of Medicine.

PMID: 16363603

No abstract available

Publication types

Review

MeSH terms

Amoxicillin / administration & dosage
Anti-Bacterial Agents / administration & dosage
Aryl Hydrocarbon Hydroxylases / genetics*
Clarithromycin / administration & dosage
Cytochrome P-450 CYP2C19
Drug Administration Schedule
Drug Therapy, Combination
Enzyme Inhibitors / administration & dosage
Helicobacter Infections / drug therapy*
Helicobacter pylori*
Humans
Metronidazole / administration & dosage
Mixed Function Oxygenases / genetics*
Omeprazole / administration & dosage
Pharmacogenetics*
Polymorphism, Single Nucleotide*
Proton Pump Inhibitors
Treatment Outcome

Substances

Anti-Bacterial Agents
Enzyme Inhibitors
Proton Pump Inhibitors
Metronidazole
Amoxicillin
Mixed Function Oxygenases
Aryl Hydrocarbon Hydroxylases
CYP2C19 protein, human
Cytochrome P-450 CYP2C19
Clarithromycin
Omeprazole